Skip to main content
Biofarm S.A. logo

Biofarm S.A. — Investor Relations & Filings

Ticker · BIO ISIN · ROBIOFACNOR9 LEI · 254900G63HUEZ1Z9UW08 RO Manufacturing
Open in API
Filings indexed 44 across all filing types
Latest filing 2026-05-28 Legal Proceedings Report
Country RO Romania
Listing RO BIO

About Biofarm S.A.

https://www.biofarm.ro/en/

Biofarm S.A. is a pharmaceutical company engaged in the manufacturing and marketing of medicines and dietary supplements. Established in 1921, the company has a significant history in the pharmaceutical sector. Its portfolio includes a wide range of products covering numerous therapeutic areas, offered in various formats such as tablets and liquids. Biofarm is a prominent manufacturer of soft gelatin capsules and markets a diverse portfolio of over-the-counter (OTC) and prescription drugs. The company focuses on developing trusted brands that support consumer health and well-being.

Recent filings

Filing Released Lang Actions
Litigii in care este implicata societatea comerciala - RC08
Legal Proceedings Report Classification · 95% confidence The document is a current report filed under F.S.A. Regulation No. 5/2018 by Biofarm S.A., detailing ongoing disputes and court hearings involving the company. It provides updates on legal proceedings, including case numbers, parties, court stages, hearing dates, and rulings. This falls squarely under Legal Proceedings Report (LTR).
2026-05-28 English
Litigii in care este implicata societatea comerciala - RC08
Legal Proceedings Report Classification · 94% confidence The document is a current report (“Raport curent”) filed under the Romanian ASF rules, detailing ongoing litigation and court dates. It does not contain full financial statements but provides updates on legal proceedings involving the company. This precisely matches the “Legal Proceedings Report” category.
2026-05-28 Romanian
Raport curent de informare a investitorilor
M&A Activity Classification · 95% confidence The document is a Current Report (under Romanian FSA Regulation 5/2018) in which the Board of Directors of Biofarm S.A. presents its formal position regarding a voluntary public takeover bid announced by Polpharma. This is clearly related to a takeover offer and thus falls under M&A Activity announcements for takeover bids. No substantive financial statements are included, nor is this merely a notice of report publication or regulatory compliance communication—it specifically addresses an M&A event.
2026-05-25 English
Raport curent de informare a investitorilor
M&A Activity Classification · 89% confidence The document is a current report (Raport Curent) filed under Romanian FSA Regulation 5/2018, detailing the Board of Directors’ position on a voluntary public takeover offer announced by Zaklady Farmaceutyczne Polpharma S.A. It is an announcement related to a takeover bid, not a financial statement or earnings release. This matches the M&A Activity category for merger and takeover-related communications.
2026-05-25 Romanian
Raport curent de informare a investitorilor
Regulatory Filings Classification · 95% confidence The document is a Current Report filed by Biofarm S.A. pursuant to F.S.A. Regulations no. 5/2018. It reports the receipt of a request from a major shareholder (Longshield Investment Group S.A.) to convene an Ordinary General Meeting of Shareholders with a specified agenda including dividend approval and bonus allocation. The document includes the shareholder's formal request, supporting documents, and draft resolutions to be voted on at the meeting. There are no financial statements or detailed financial analysis present, only a notification of a shareholder meeting request and proposed agenda items. This fits the definition of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not constitute an Annual Report, Interim Report, or any other detailed financial or management report. The document length (6321 characters) and content confirm it is not merely a brief announcement but a full regulatory current report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-05-08 English
Raport curent de informare a investitorilor
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a current report (Raport Curent) filed under ASF Regulation 5/2018, dated 08.05.2026, by Biofarm S.A. It informs shareholders about a request from a major shareholder (Longshield Investment Group S.A.) holding 51.6787% of shares to convene an Annual General Meeting (AGOA) with specific agenda items including approval of a special dividend and a bonus for management and employees. The document includes the request letter, shareholder details, and draft resolutions for the meeting. It is not the actual AGM materials or minutes but a formal announcement related to the convening of the AGM and the agenda. It also contains voting result placeholders but no actual voting results. Therefore, it is best classified as a Declaration of Voting Results & Voting Rights Announcements (DVA) because it relates to shareholder voting matters and meeting convocations, although the actual voting results are not yet filled in. The document is over 6000 characters and contains substantive content about shareholder meeting and voting matters, not just a brief announcement or invitation, so it is not RPA or PSI. It is not an Annual Report, Earnings Release, or Management Report. Hence, the most appropriate classification is DVA with high confidence.
2026-05-08 Romanian

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.